Follow The Filings

ALB Albemarle

Albemarle earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 2.55 — —
Rev $1.57B — —

Insider trades

Open-market buys and sales by ALB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALB insider trades
  • None no insider bought on the open market
  • $7.4M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. J Kent Masters CEO
    Sale
    $3M 16,393 shares at $183.72 16% of stake
    Traded May 15 Filed May 19
  2. J Kent Masters CEO
    Sale
    $2M 11,783 shares at $170.81 8% of stake
    Traded Mar 10 Filed Mar 12
  3. Eric Norris Chief Commercial Officer
    Sale
    $942K 5,692 shares at $165.45 10% of stake
    Traded Feb 20 Filed Feb 23
  4. Melissa H. Anderson Chief Bus..Transformation Off.
    Sale
    $1.4M 8,454 shares at $163.71 47% of stake
    Traded Feb 13 Filed Feb 18
  5. Ander C. Krupa General Counsel & Sec
    Planned sale
    $18K 172 shares at $105.00 1.5% of stake
    Traded Oct 24, 2025 Filed Oct 28, 2025
  6. Ander C. Krupa General Counsel & Sec
    Planned sale
    $11K 116 shares at $95.00 1% of stake
    Traded Oct 9, 2025 Filed Oct 14, 2025

Also filed in the last 12 months, not counted as buying or selling: 38 stock grants, 24 share withholdings for taxes, 3 option exercises, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 1.01,1.02,2.03,5.03,9.01
SCHEDULE 13G —
8-K 5.02,7.01,9.01
8-K 5.02
8-K 2.02,9.01
10-Q
8-K 5.02,7.01,9.01
8-K 5.02
SCHEDULE 13G/A —
8-K 5.02,5.07,9.01
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
8-K 5.02
10-K/A
SCHEDULE 13G/A —
8-K 1.01,9.01
DEF 14A
DEFA14A
8-K 2.01,7.01,8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.